Company Profile LogoGain Therapeutics

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Edit IconSuggest an Edit
Health Care
Therapeutics
Pharmaceutical
Biotechnology

    Unlock insights on Gain Therapeutics and 2M+ companies now!

    About Gain Therapeutics

    Gain Therapeutics is a developer of pharmacological chaperones drugs designed to treat rare metabolic disorders. The company's drugs utilize Minoryx Direct Enzyme Therapy to identify a new generation of uncomplicated adjuvants, enabling clients to help patients stabilize misfolding mutations and restore protein's enzymatic activity. It targets lysosomal enzymes to develop innovative drugs for rare pediatric genetic disorders and selected CNS diseases with high unmet medical needs. Established i

    Repeat Founder
    Company Highlights
    Year Founded

    2017

    icon-altEmployees

    33

    Location (HQ)

    USA

    Since Last Funding

    9 months

    Monthly Website Visitors

    15.4K

    icon-altTotal Investment Amt

    $24M

    Last Funding Round

    Post Ipo Equity

    icon-altMoM Headcount Growth

    -2.93%

    icon-altYoY Headcount Growth

    -8.31%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Pharmaceutical

    Health Care

    Biotechnology

    Biotechnology Research

    Therapeutics